New Zealand markets closed

RenovoRx, Inc. (RNXT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.1300-0.0200 (-1.74%)
At close: 04:00PM EDT
1.0200 -0.11 (-9.73%)
After hours: 07:30PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
4,626
5,667
4,301
3,039
2,386
-
Selling general and administrative
5,510
5,729
5,649
2,632
818
-
Total operating expenses
10,136
11,396
9,950
5,671
3,204
-
Operating income or loss
-10,136
-11,396
-9,950
-5,671
-3,204
-
Interest expense
-
-
-
834
590
0
Total other income/expenses net
4
1,709
4
181
-7
-
Income before tax
-10,088
-10,232
-9,889
-6,324
-3,798
-
Income from continuing operations
-10,088
-10,232
-9,889
-6,324
-3,798
-
Net income
-10,088
-10,232
-9,889
-6,324
-3,798
-
Net income available to common shareholders
-10,088
-10,232
-9,889
-6,324
-3,798
-
Basic EPS
-0.92
-
-1.09
-1.21
-0.45
-0.46
Diluted EPS
-0.92
-
-1.09
-1.21
-0.45
-0.46
Basic average shares
9,888
-
9,052
5,217
8,384
8,384
Diluted average shares
9,888
-
9,052
5,217
8,384
8,384